domingo, 24 de marzo de 2013

National Guideline Clearinghouse | Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer.

full-text ►
National Guideline Clearinghouse | Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer.

National Guideline Clearinghouse (NGC)

March 18, 2013



Guideline Title
Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer.
 
Bibliographic Source(s)
Alberta Provincial Breast Tumour Team. Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer. Edmonton (Alberta): Alberta Health Services, Cancer Care; 2011 Jun. 10 p. (Clinical practice guideline; no. BR-003).  [42 references]
 
Guideline Status
This is the current release of the guideline.

No hay comentarios:

Publicar un comentario